Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gatzemeier

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesotheliomaC Manegold, J Symanowski, U Gatzemeier, et al.
The European Respiratory Journal|May 19, 2006
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapyA R Wewel, J A M Crusius, U Gatzemeier, et al.
Seminars in Oncology|April 16, 1998
Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancerU Gatzemeier, C Manegold, W Eberhard, et al.
Seminars in Oncology|June 1, 1997
A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancerU Gatzemeier, C Manegold, W Eberhard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyV Trillet-Lenoir, J Green, C Manegold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patientsP J Souquet, E H Tan, J Rodrigues Pereira, et al.
Nuclear Medicine Communications|March 1, 1996
Somatostatin receptor scintigraphy in the staging of small cell lung cancerK H Bohuslavizki, W Brenner, M Günther, et al.
Anti-Cancer Drugs|April 11, 2000
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancerK Mattson, J Vansteenkiste, R Stupp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2009
Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancerE H Tan, J Rolski, T Grodzki, et al.
American Journal of Clinical Oncology|August 24, 2000
Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized studyU Gatzemeier, J P Kleisbauer, P Drings, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesotheliomaC Manegold, J Symanowski, U Gatzemeier, et al.
The European Respiratory Journal|May 19, 2006
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapyA R Wewel, J A M Crusius, U Gatzemeier, et al.
Seminars in Oncology|April 16, 1998
Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancerU Gatzemeier, C Manegold, W Eberhard, et al.
Seminars in Oncology|June 1, 1997
A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancerU Gatzemeier, C Manegold, W Eberhard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapyV Trillet-Lenoir, J Green, C Manegold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2002
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patientsP J Souquet, E H Tan, J Rodrigues Pereira, et al.
Nuclear Medicine Communications|March 1, 1996
Somatostatin receptor scintigraphy in the staging of small cell lung cancerK H Bohuslavizki, W Brenner, M Günther, et al.
Anti-Cancer Drugs|April 11, 2000
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancerK Mattson, J Vansteenkiste, R Stupp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2009
Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancerE H Tan, J Rolski, T Grodzki, et al.
American Journal of Clinical Oncology|August 24, 2000
Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized studyU Gatzemeier, J P Kleisbauer, P Drings, et al.
Pageof 8